The effects of sequence variation on genome-wide NRF2 binding-new target genes and regulatory SNPs.

  • Clinical and Applied Virology
February 29, 2016 By:
  • Kuosmanen SM
  • Viitala S
  • Laitinen T
  • Perakyla M
  • Polonen P
  • Kansanen E
  • Leinonen H
  • Raju S
  • Wienecke-Baldacchino A
  • Narvanen A
  • Poso A
  • Heinaniemi M
  • Heikkinen S
  • Levonen AL.

Transcription factor binding specificity is crucial for proper target gene regulation. Motif discovery algorithms identify the main features of the binding patterns, but the accuracy on the lower affinity sites is often poor. Nuclear factor E2-related factor 2 (NRF2) is a ubiquitous redox-activated transcription factor having a key protective role against endogenous and exogenous oxidant and electrophile stress. Herein, we decipher the effects of sequence variation on the DNA binding sequence of NRF2, in order to identify both genome-wide binding sites for NRF2 and disease-associated regulatory SNPs (rSNPs) with drastic effects on NRF2 binding. Interactions between NRF2 and DNA were studied using molecular modelling, and NRF2 chromatin immunoprecipitation-sequence datasets together with protein binding microarray measurements were utilized to study binding sequence variation in detail. The binding model thus generated was used to identify genome-wide binding sites for NRF2, and genomic binding sites with rSNPs that have strong effects on NRF2 binding and reside on active regulatory elements in human cells. As a proof of concept, miR-126-3p and -5p were identified as NRF2 target microRNAs, and a rSNP (rs113067944) residing on NRF2 target gene (Ferritin, light polypeptide, FTL) promoter was experimentally verified to decrease NRF2 binding and result in decreased transcriptional activity.

2016 Feb. Nucleic Acids Res.44(4):1760-75. Epub 2016 Jan 29.
Other information